The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study
| dc.authorid | Gurses, Murat Serdar/0000-0002-9982-0476|Turkmen Inanir, Nursel/0000-0002-4047-6455; | |
| dc.contributor.author | Pehlivan, Sultan | |
| dc.contributor.author | Gurses, Murat Serdar | |
| dc.contributor.author | Ural, Mustafa Numan | |
| dc.contributor.author | Akyol, Sumeyya | |
| dc.contributor.author | Eren, Filiz | |
| dc.contributor.author | Inanir, Nursel Turkmen | |
| dc.contributor.author | Gulec, Mehmet Akif | |
| dc.date.accessioned | 2025-10-24T18:09:16Z | |
| dc.date.available | 2025-10-24T18:09:16Z | |
| dc.date.issued | 2016 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Objective: To determine the role of a disintegrin and metalloproteinase with thrombospondin type 1 motif (ADAMTS1) and fragmented versican in the myocardial infarction (MI) process in humans and to evaluate the diagnostic efficacy of ADAMTS1 for postmortem diagnosis of MI. Methods: Thirty autopsied individuals were allocated into 2 groups, namely, a study group of individuals who died of myocardial infarction (n = 20), and a control group who died of trauma (n = 10). We performed standard immunohistochemical staining on myocardial tissue specimens, studying anti-ADAMTS1, anti-versican, and anti-versican C terminal peptide sequence (DPEAAE) fragments. Results: Strong, diffuse staining was observed throughout myocardial tissue for ADAMTS1 in the 2 groups. However, in the study group, we observed no expression for ADAMTS1 around fibrotic areas but detected slight staining in coagulative and necrotic zones. Conclusion: Similar localizations of ADAMTS and fragmented versican in human heart tissue indicate that versican presumably is cleaved by ADAMTS1. Hence, ADAMTS1 can be regarded as a new marker for postmortem differential diagnosis of MI. | |
| dc.identifier.doi | 10.1093/labmed/lmw022 | |
| dc.identifier.endpage | 212 | |
| dc.identifier.issn | 0007-5027 | |
| dc.identifier.issn | 1943-7730 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmid | 27346868 | |
| dc.identifier.scopus | 2-s2.0-85014440250 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 205 | |
| dc.identifier.uri | https://doi.org/10.1093/labmed/lmw022 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3561 | |
| dc.identifier.volume | 47 | |
| dc.identifier.wos | WOS:000381879800007 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Oxford Univ Press | |
| dc.relation.ispartof | Laboratory Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | ADAMTS1; myocardial infarction; versican; fragmented versican; postmortem; diagnosis | |
| dc.title | The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study | |
| dc.type | Article |












